On December 1, 2025, the Office of the United States Trade Representative, the Department of Commerce, and the Department of Health and Human Services announced an agreement with the United Kingdom (U ...
The White House said the agreements will reduce costs to treat Parkinson's disease, macular degeneration, glaucoma, liver ...
A deal with pharmaceutical companies may not be as far-reaching as the administration says, according to experts.
Nine more pharmaceutical companies said they would cut the prices on some drugs through Trump’s Most Favored Nation program.
The U.S. has now reached 26 such deals covering 89% of the branded drug market, the White House said.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results